Changes in gut microbiota in the acute phase after spinal cord injury correlate with severity of the lesion.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
17 06 2021
Historique:
received: 28 01 2021
accepted: 31 05 2021
entrez: 18 6 2021
pubmed: 19 6 2021
medline: 9 11 2021
Statut: epublish

Résumé

After spinal cord injury (SCI), patients face many physical and psychological issues including intestinal dysfunction and comorbidities, strongly affecting quality of life. The gut microbiota has recently been suggested to influence the course of the disease in these patients. However, to date only two studies have profiled the gut microbiota in SCI patients, months after a traumatic injury. Here we characterized the gut microbiota in a large Italian SCI population, within a short time from a not only traumatic injury. Feces were collected within the first week at the rehabilitation center (no later than 60 days after SCI), and profiled by 16S rRNA gene-based next-generation sequencing. Microbial profiles were compared to those publicly available of healthy age- and gender-matched Italians, and correlated to patient metadata, including type of SCI, spinal unit location, nutrition and concomitant antibiotic therapies. The gut microbiota of SCI patients shows distinct dysbiotic signatures, i.e. increase in potentially pathogenic, pro-inflammatory and mucus-degrading bacteria, and depletion of short-chain fatty acid producers. While robust to most host variables, such dysbiosis varies by lesion level and completeness, with the most neurologically impaired patients showing an even more unbalanced microbial profile. The SCI-related gut microbiome dysbiosis is very likely secondary to injury and closely related to the degree of completeness and severity of the lesion, regardless of etiology and time interval. This microbial layout could variously contribute to increased gut permeability and inflammation, potentially predisposing patients to the onset of severe comorbidities.

Identifiants

pubmed: 34140572
doi: 10.1038/s41598-021-92027-z
pii: 10.1038/s41598-021-92027-z
pmc: PMC8211659
doi:

Substances chimiques

RNA, Ribosomal, 16S 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12743

Références

Best Pract Res Clin Gastroenterol. 2009;23(4):531-43
pubmed: 19647688
Bioinformatics. 2005 Jun 1;21(11):2789-90
pubmed: 15797915
J Atheroscler Thromb. 2017 Feb 1;24(2):110-119
pubmed: 27928097
Neurogastroenterol Motil. 2010 Dec;22(12):e340-9
pubmed: 20879994
Am J Gastroenterol. 1997 May;92(5):891-4
pubmed: 9149209
Gut Microbes. 2020 Nov 9;12(1):1707610
pubmed: 31924126
Nat Microbiol. 2019 Apr;4(4):623-632
pubmed: 30718848
Clin Gastroenterol Hepatol. 2019 Mar;17(4):756-765.e3
pubmed: 30036646
Genome Med. 2016 Apr 21;8(1):43
pubmed: 27102666
Dis Esophagus. 2015 Oct;28(7):699-704
pubmed: 25224683
Nat Med. 2018 Oct;24(10):1526-1531
pubmed: 30150717
Spinal Cord. 2000 Oct;38(10):615-21
pubmed: 11093323
Gastroenterology. 1990 Mar;98(3):686-93
pubmed: 2404826
World J Gastroenterol. 2010 Nov 21;16(43):5435-9
pubmed: 21086560
Phys Med Rehabil Clin N Am. 2014 Aug;25(3):505-17, vii
pubmed: 25064785
Spinal Cord. 2013 Sep;51(9):683-7
pubmed: 23774126
Nat Med. 2019 Jul;25(7):1096-1103
pubmed: 31263284
Am J Gastroenterol. 2003 Jan;98(1):128-34
pubmed: 12526948
Nature. 2019 May;569(7758):641-648
pubmed: 31142853
Gut. 1997 Sep;41(3):381-9
pubmed: 9378396
World J Gastroenterol. 2011 Dec 14;17(46):5035-48
pubmed: 22171138
Aliment Pharmacol Ther. 2015 Jul;42(1):71-83
pubmed: 25973666
Nat Commun. 2016 Jun 28;7:12015
pubmed: 27352007
Sci Rep. 2016 Sep 14;6:32826
pubmed: 27624970
J Med Chem. 2018 Jan 11;61(1):47-61
pubmed: 28745893
Cell Host Microbe. 2010 Sep 16;8(3):292-300
pubmed: 20833380
mSphere. 2016 Aug 31;1(4):
pubmed: 27602409
Neurosurg Focus. 2019 Mar 1;46(3):E11
pubmed: 30835680
Gut. 2016 Nov;65(11):1812-1821
pubmed: 26416813
Curr Biol. 2016 Jun 6;26(11):1480-5
pubmed: 27185560
Bioinformatics. 2010 Oct 1;26(19):2460-1
pubmed: 20709691
PLoS One. 2016 Jan 11;11(1):e0145878
pubmed: 26752409
Neurobiol Pain. 2020 Dec 11;9:100056
pubmed: 33392418
Science. 2016 Apr 29;352(6285):565-9
pubmed: 27126040
BMC Bioinformatics. 2012 Feb 14;13:31
pubmed: 22333067
Front Microbiol. 2016 Aug 23;7:1297
pubmed: 27602022
Gut. 2016 Jan;65(1):57-62
pubmed: 26069274
J Exp Med. 2016 Nov 14;213(12):2603-2620
pubmed: 27810921
Intest Res. 2019 Jul;17(3):419-426
pubmed: 30704159
Am J Physiol Gastrointest Liver Physiol. 2009 Jun;296(6):G1344-9
pubmed: 19359420
Nat Commun. 2014 Apr 15;5:3654
pubmed: 24736369
PLoS One. 2018 Aug 1;13(8):e0200322
pubmed: 30067768
Nutrients. 2019 Dec 10;11(12):
pubmed: 31835452
Arch Phys Med Rehabil. 2015 Jan;96(1):49-55
pubmed: 25172370
PLoS One. 2019 Aug 8;14(8):e0220619
pubmed: 31393934
Nat Med. 2018 Oct;24(10):1532-1535
pubmed: 30150716
Clin Gastroenterol Hepatol. 2019 Jan;17(2):322-332
pubmed: 30292888
BMC Med Genomics. 2019 Mar 7;12(1):49
pubmed: 30845942
Mol Nutr Food Res. 2019 Apr;63(7):e1800870
pubmed: 30636111
Nutrients. 2019 Dec 04;11(12):
pubmed: 31817158
Int J Obes (Lond). 2012 Jun;36(6):817-25
pubmed: 21829158
Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):10713-10718
pubmed: 28893978
Nutrients. 2018 Jun 01;10(6):
pubmed: 29857583
BMC Microbiol. 2016 Nov 28;16(1):284
pubmed: 27894251
Gastroenterology. 1984 Feb;86(2):287-94
pubmed: 6690355
J Transl Med. 2018 Dec 13;16(1):353
pubmed: 30545398
Am J Infect Control. 2016 Jul 1;44(7):830-6
pubmed: 26905790
Trends Microbiol. 2016 Jul;24(7):523-524
pubmed: 26996766
Gastroenterology. 2016 Feb;150(2):300-3
pubmed: 26710987
Clin Gastroenterol Hepatol. 2019 Jan;17(2):256-274
pubmed: 30153517
Rehabil Nurs. 2012 May-Jun;37(3):128-35
pubmed: 22549630
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
PLoS One. 2017 Mar 22;12(3):e0174099
pubmed: 28328981
Lancet. 1996 Jun 15;347(9016):1651-3
pubmed: 8642958
Curr Gastroenterol Rep. 2018 Aug 29;20(10):47
pubmed: 30159690
Infection. 2018 Dec;46(6):751-760
pubmed: 30003491
Science. 2016 Apr 29;352(6285):560-4
pubmed: 27126039
Neurotherapeutics. 2018 Jan;15(1):60-67
pubmed: 29101668
Nat Med. 2018 Apr 10;24(4):392-400
pubmed: 29634682
Dig Dis Sci. 2011 Aug;56(8):2361-5
pubmed: 21384123
Nat Commun. 2017 Dec 5;8(1):1784
pubmed: 29209090
Gastroenterology. 1989 May;96(5 Pt 1):1265-73
pubmed: 2703114
Gastroenterology. 2010 May;138(5):1663-6
pubmed: 20332039
Gut. 2012 Jul;61(7):1007-15
pubmed: 22301383
Microb Genom. 2019 Sep;5(9):
pubmed: 31526447
J Physiol. 2016 Aug 1;594(15):4099-116
pubmed: 26990133
Science. 2017 Aug 11;357(6351):570-575
pubmed: 28798125
Nature. 2018 Mar 8;555(7695):210-215
pubmed: 29489753

Auteurs

Gabriele Bazzocchi (G)

Neurogastroenterology Unit, Montecatone Rehabilitation Institute, via Montecatone 37, 40026, Imola, Bologna, Italy. gabriele.bazzocchi@unibo.it.

Silvia Turroni (S)

Unit of Microbiome Science and Biotechnology, Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.

Maria Chiara Bulzamini (MC)

Spinal Unit, Montecatone Rehabilitation Institute, Imola, Bologna, Italy.

Federica D'Amico (F)

Unit of Microbiome Science and Biotechnology, Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Angelica Bava (A)

ASST Gaetano Pini CTO, Milan, Italy.

Mirco Castiglioni (M)

ASST Gaetano Pini CTO, Milan, Italy.

Valentina Cagnetta (V)

ICS Maugeri, Bari, Italy.

Ernesto Losavio (E)

ICS Maugeri, Bari, Italy.

Maurizio Cazzaniga (M)

Ospedale Valduce, Costa Masnaga, Lecco, Italy.

Laura Terenghi (L)

Ospedale Valduce, Costa Masnaga, Lecco, Italy.

Luisa De Palma (L)

Ospedale Policlinico, Bari, Italy.

Giuseppina Frasca (G)

Ospedale Policlinico, Bari, Italy.

Beatrice Aiachini (B)

ICS Maugeri, Pavia, Italy.

Sonia Cremascoli (S)

ICS Maugeri, Pavia, Italy.

Antonino Massone (A)

Ospedale Santa Corona, Pietra Ligure, Savona, Italy.

Claudia Oggerino (C)

Ospedale Santa Corona, Pietra Ligure, Savona, Italy.

Maria Pia Onesta (MP)

Ospedale Cannizzaro, Catania, Italy.

Lucia Rapisarda (L)

Ospedale Cannizzaro, Catania, Italy.

Maria Cristina Pagliacci (MC)

Azienda Ospedaliera, Perugia, Italy.

Sauro Biscotto (S)

Azienda Ospedaliera, Perugia, Italy.

Michele Scarazzato (M)

Fondazione Teresa Camplani, Domus Salutis, Brescia, Italy.

Tiziana Giovannini (T)

Montecatone Rehabilitation Institute, Imola, Bologna, Italy.

Mimosa Balloni (M)

Neurogastroenterology Unit, Montecatone Rehabilitation Institute, via Montecatone 37, 40026, Imola, Bologna, Italy.

Marco Candela (M)

Unit of Microbiome Science and Biotechnology, Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.

Patrizia Brigidi (P)

Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Carlotte Kiekens (C)

Spinal Unit, Montecatone Rehabilitation Institute, Imola, Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH